Moderate amounts of viral inhibitor were produced by mouse embryo (ME) cultures infected with two strains of plaque-purified murine cytomegalovirus (MCV). This inhibitor was shown to be interferon, based on the possession of similar properties. The growth studies of MCV in ME cells showed that interferon was produced as early as 4 h after infection, infectious virus was produced between 12 to 16 h, and cytopathic effect was produced between 16 to 18 h. Since MCV-induced interferon production and the subsequent development of antiviral state occurred early, the long eclipse period may be due to an interferonmediated delay of virus replication. Pretreatment of ME cells with varying concentrations of interferon before infection with MCV did not result in increased interferon production, but at high pretreatment doses a slight inhibitory effect on interferon production was observed. In vitro sensitivity studies showed that small doses of MCV were highly sensitive to the antiviral action of interferon, but higher viral doses proved to be markedly resistant. Although the available evidence does not permit a definitive interpretation of the mechanism by which MCV may show differing sensitivities to interferon action, the presence of a small interferon-resistant fraction of virus-infected cells may account for the observations. Murine and human cytomegaloviruses (CV) generally induce little or undetectable amounts of interferon (15, 16, 18, 28, 34) . Actually, they may even actively inhibit interferon production. In addition, these viruses are reported to be relatively resistant to the antiviral action of interferon (16, 28) . The present study was undertaken to reevaluate the role of interferon during MCV infection in vitro using an improved interferon assay and high-titered interferon preparations. The results indicated that (i) the sensitivity of CV in cell culture is highly dependent on the challenge dose of CV used in the assay, (ii) the strains of MCV used in the present study induced moderate amounts of interferon in mouse embryo (ME) cells, and (iii) interferon was detectable in the medium of infected mouse cultures 8 to 12 h before infectious virus.
Murine and human cytomegaloviruses (CV) generally induce little or undetectable amounts of interferon (15, 16, 18, 28, 34) . Actually, they may even actively inhibit interferon production. In addition, these viruses are reported to be relatively resistant to the antiviral action of interferon (16, 28) . The present study was undertaken to reevaluate the role of interferon during MCV infection in vitro using an improved interferon assay and high-titered interferon preparations. The results indicated that (i) the sensitivity of CV in cell culture is highly dependent on the challenge dose of CV used in the assay, (ii) the strains of MCV used in the present study induced moderate amounts of interferon in mouse embryo (ME) cells, and (iii) interferon was detectable in the medium of infected mouse cultures 8 to 12 h before infectious virus.
MATERIALS AND METHODS Cell cultures. Secondary ME cultures were prepared from primary cells, derived from 14-to 16-dayold NIH Swiss embryos. The growth medium for ME cells consisted of Eagle reinforced medium (2) supplemented with 10% heat-inactivated fetal bovine serum and antibiotics. The experimental medium was the same, except the serum content was reduced to 2% (REM2). Mouse L cells were cultured in suspension in Eagle spinner medium plus 10% fetal bovine serum. However, for experimental purposes, Eagle minimal essential medium containing 2% fetal bovine serum was used. All experiments were conducted with cells grown at 37 C in tubes (16 (3) . Its titer was 104-5 U/ml.
Preparation of MCV-induced viral inhibitor. Secondary ME cultures were infected with MCV at an input multiplicity of infection (MOI) of 1 to 5.
After an adsorption period of 2 h at 37 C, the cultures were washed twice with Earle balanced salt solution, fed with REM2, and incubated at 37 C until the cytopathic effect (CPE) had involved 75 to 100% of the cell sheet. The medium was harvested, pH 2-treated overnight at 4 C, readjusted to pH 7, and clarified by centrifugation at 1,500 rpm for 10 min.
Interferon assay. The antiviral activities of MSIand MCV-induced viral inhibitor were determined by the GD-VII hemagglutinin yield reduction method in mouse L cells (27) . In every assay performed, a standard laboratory mouse serum interferon containing 104-5 U/ml was titrated in parallel. The standard reference mouse serum interferon (no. G002-902-026) also titered 104-5 U/ml by this assay.
RESULTS
Production and detection of viral inhibitor. Antiviral activity was initially demonstrated in fluids from ME cultures infected with CV201-3 (the strain contaminated with polyoma virus), but the titers were consistently low (Table 1 ). In contrast, viral inhibitor production by ME cells infected with the polyoma-free substrains, MCV-P1 and MCV-P2, was significantly greater (P < 0.01 and P < 0.005, respectively).
Due to the differences reported in the detection of interferon production by MCV-infected cell cultures, an additional effort was made to confirm the requirement of MCV infection for the production of the viral inhibitor by secondary ME cells. Aliquots of MCV-P2 or CV201-3 were mixed with either normal mouse serum or sufficient mouse anti-MCV serum (prepared against a polyoma virus-free MCV pool) to completely neutralize virus infectivity when incubated for 1 h at 37 C. Fresh secondary ME cultures were infected with neutralized MCV and normal serum-treated MCV, as well as the untreated virus. As controls, secondary ME cultures were exposed to medium in place of virus. When the cultures exposed to infectious virus showed 75 to 100% CPE, the fluids from all cultures were harvested and assayed for antiviral activity. At the time the fluids were harvested, CPE in cultures infected with normal serum-treated MCV was comparable to that seen in cultures infected with virus not exposed to serum. A set of cultures infected with antibody-neutralized virus showed no CPE 7 days postinfection. The results ( 
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Characterization of the viral inhibitor. Some of the physical, chemical, and biological properties of the viral inhibitor produced by MCV-infected secondary ME cultures were determined. It was stable at pH 2 for 24 h at 4 C; the antiviral activity was cell bound and could not be removed by repeated washings; and it was not sedimented at 38,000 rpm for 3.5 h. Exposure to 0.2 mg of trypsin per ml for 1 h at 37 C completely destroyed the antiviral activity, indicating the protein nature of the inhibitor. Species specificity was shown by the protection of mouse L and secondary ME cultures but not chicken, rabbit, or human cells. Fifty-to 100-fold less antiviral action was observed in rat embryo cells. Finally, antiviral action was demonstrated against VSV, GD-VII virus, and Sindbis virus, showing that the action of the inhibitor affected several unrelated viruses. These properties are consistent with those of interferon (25) . 20 kc/s, 4 C), a fuged (2,000 rpm, 10 min). The su fluids were divided into two aliquots. used to determine virus production I assay; the other was assayed for inte Viral CPE was first observed 16 to 1, fection and consisted of a few indivi appearing swollen and rounded. At 2 50% of the cell monolayer showed many areas, the cells which had enli rounded up had formed large aggrega cells were also observed in areas of C h, 90 to 100% of the cells were involv production was initially detected 12 to infection (Fig. 1) , slightly earlier thai observation of CPE. Thereafter, the a was essentially linear until 36 to 4E CPE and imal (90 to 100%) CPE. Interferon, however, iples were was detectable in the fluids from MCV-infected 4d and the cultures as early as 4 h after infection. Producre pooled, tion increased until about 36 to 48 h, when nd centri-maximal titers (2.0 to 2.6 log10 U/ml) were atpernatant tained. One was MCV-induced interferon production by by plaque ME cells pretreated with interferon. Experi-,rferon.
ments were done to determine whether pretreat-8 h postin-ment of ME cells with interferon affected subsedual cells quent interferon production induced by MCV. A4 h, 25 to ME cells were exposed to interferon concentra-CPE. In tions ranging from 10 to 1,000 U/culture for 24 h arged and before infection with either MCV-P2 (MOI = 5) tes. Giant or with Sindbis virus (MOI = 10). Sindbis virus PE. By 48 challenge was used to determine the resistred. Virus ance developed after exposure to the various 16 h after concentrations of interferon. These cultures n the first were harvested 24 h after infection and virus roduction yields were determined by the hemagglutina-5 h, when tion assay using gander erythrocytes (8) . Resistance is expressed as the log10 reduction in hemagglutinin yields in interferon-treated cultures (Table 3) . However, at 100 U per < culture or more, a slight but probably insignifim cant reduction of interferon yields was ob--served. In addition, at interferon pretreatment _30 o levels (640 to 1,000 U/culture) which resulted _ ) in complete protection against Sindbis virusinduced CPE, changes suggestive of MCV-inz duced CPE were observed, suggesting that 2.0 -MCV was less sensitive than Sindbis virus to -X the action of interferon. dium every 3rd day. When the cells that had not received interferon showed 75 to 100% CPE, the cultures were frozen at -20 C until virus yields were determined by plaque assay in secondary ME cells. The results showed that interferon-induced resistance to MCV-P2 was inversely related to the virus dose (Table 4) . At low viral input, significant yield reductions were demonstrated; however, as the dose was increased, even continuous treatment with 100 U of interferon was not able to protect the cells or reduce virus yields significantly.
Based on the results in Table 4 , the titer of the interferon preparation used in this experiment was 1,600 U/ml when an MCV challenge dose of 10 PFU/culture was used; however, if an MCV dose of 10,000 PFU was used, the anti- viral activity would be <16 U/ml. In contrast, interferon titers obtained by using small (multiple growth cycles) or large (single growth cycles) challenge doses of another virus (VSV) were not found to be significantly different (17) . Similarly, in the present study a Sindbis virus challenge dose of 10650 PFU was markedly inhibited (Table 4) . DISCUSSION Although some investigators have reported the detection of interferon production during CV infection (15, 18, 34) , others have not (16, 28) . In the present study, two plaque-purified strains of MCV were found to induce moderate amounts of interferon in ME cultures. This inhibitor was shown to be interferon based on the possession of similar properties. Moreover, this interferon was produced as a result of MCV infection because (i) antiviral activity could be demonstrated only in fluids from MCV-infected cultures, and (ii) neutralization ofvirus infectivity with specific anti-MCV serum rendered the virus noninfectious and incapable of inducing interferon production. The results reported here confirm the findings of Henson and Smith (18) but do not provide an explanation as to why others (28) have failed to detect interferon in MCV-infected culture fluids. One possibility may be the presence of an undetected agent (e.g., polyoma virus) in the stock MCV preparation which might interfere with MCV-induced interferon production, as was probably the case early in this study. Another possibility may be the presence of interferon antagonists in the preparations tested for antiviral activity (6, 7, 12, 13, 14, 31, 33) . Still another possibility could be the use of an interferon assay of low sensitivity.
Interferon synthesis in ME cells began very early (4 h) after MCV infection, yet maximum titers were not reached until 36 to 48 h. In contrast, interferon was not detected until 7 to 8 h postinfection in mouse L cells infected with the Roakin strain of NDV (21) and 10 to 12 h after infection of ME cells with the Herts strain of NDV (Oie, unpublished data) . In both cases, NDV-induced interferon production peaked within 24 h. Thus, MCV-induced interferon production began earlier but peaked at a much later time than NDV-induced production.
MCV growth in ME cells was characterized by a long eclipse period; new infectious virus was not detected until 12 to 16 h after infection.
CPE was observed 4 to 6 h later. VSV challenge during the eclipse period (first 12 h postinfection) showed that the cells had developed sufficient resistance to reduce VSV yields by 10-to VOL. 12, 1975 16-fold (Oie, unpublished data Inhibition of virus replication by treating ME cells with interferon before infection with MCV did not result in increased interferon production (priming effect), but at high pretreatment doses a modest reduction in MCV-induced interferon yields was observed. A similar but more pronounced state of refractoriness to interferon production was reported for mouse L cells treated with interferon preceding induction with NDV (Herts strain) (26) .
Several investigators have reported that the CV were not sensitive to interferon action (16, 28) . Rabson et al. (29) , however, showed that the in vitro replication of human CV could be inhibited provided that sufficient quantities of interferon and an interferon-sensitive cell system were used. Our results with murine CV confirm the findings of these investigators. When high concentrations of interferon were used against low doses of MCV, significant inhibition of virus yields was observed. However, even high concentrations of interferon were not measurably effective against large challenge doses of MCV.
Other investigators (22) , using a plaque reduction assay, found that cell-associated CV was highly resistant to the antiviral action of interferon, whereas cell-free CV was very sensitive. They suggested that the resistance of the cell-associated virus might be due to the production of antagonists to interferon by the infected cells. In a study not reported here, we had found that ME cells infected with MCV did not produce interferon antagonists.
Protection of the intact animal by interferon is highly dependent on the virus challenge dose (4, 5) . In contrast, most investigators have found that the titer of an interferon sample assayed in cell cultures was independent of the dose of virus used (10, 17, 20, 23, 24) . In two early reports, however, a minimal decrease in interferon sensitivity was observed in vitro as the virus challenge dose (Sindbis virus and M6 virus) was increased (11, 19, 30) . More recently a strong dose dependency was reported for herpes simplex virus inhibition by rabbit interferon (35) . A virus challenge dose dependency was also observed in repeated experiments in which interferon-treated human cells were infected with the AD-169 strain of human CV (J. M. Easton, unpublished observations). Similarly, in the present study, small doses of murine CV were found to be sensitive to interferon action, whereas large doses were highly resistant. Thus, CV and herpes simplex virus are the only clear examples of viruses which manifest strong virus dose dependency to interferon action in vitro. It would be of interest to know whether other members of the herpesvirus group manifest similar virus dose dependency to interferon action.
A possible interpretation is based on the occurrence of a small fraction (0.1 to 15%) of virusinfected cells which are relatively resistant to the antiviral action of interferon (32) . Very small infecting doses of virus would have a low probability of establishing interferon-resistant infected cells, whereas large doses of virus would have a high probability of establishing such resistant, infected,cells. A partial test of this hypothesis would be an in vitro study correlating the effect of virus challenge dose on interferon sensitivity with the magnitude of the resistant fraction in different virus-cell systems.
